Your browser doesn't support javascript.
loading
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance.
Vicentini, Caterina; Cantù, Cinzia; Antonello, Davide; Simbolo, Michele; Mafficini, Andrea; Luchini, Claudio; Rusev, Borislav; Porcaro, Antonio Benito; Iacovelli, Roberto; Fassan, Matteo; Corbo, Vincenzo; Brunelli, Matteo; Artibani, Walter; Scarpa, Aldo; Lawlor, Rita T.
Affiliation
  • Vicentini C; ARC-NET Research Centre, University of Verona, Verona, Italy; Department of Diagnostics and Public Health, Section of Anatomical Pathology, University and Hospital Trust of Verona, Verona, Italy.
  • Cantù C; ARC-NET Research Centre, University of Verona, Verona, Italy.
  • Antonello D; ARC-NET Research Centre, University of Verona, Verona, Italy; Department of Surgery, General Surgery B, University of Verona, Verona, Italy.
  • Simbolo M; ARC-NET Research Centre, University of Verona, Verona, Italy; Department of Diagnostics and Public Health, Section of Anatomical Pathology, University and Hospital Trust of Verona, Verona, Italy.
  • Mafficini A; ARC-NET Research Centre, University of Verona, Verona, Italy.
  • Luchini C; Department of Diagnostics and Public Health, Section of Anatomical Pathology, University and Hospital Trust of Verona, Verona, Italy.
  • Rusev B; ARC-NET Research Centre, University of Verona, Verona, Italy; Department of Diagnostics and Public Health, Section of Anatomical Pathology, University and Hospital Trust of Verona, Verona, Italy.
  • Porcaro AB; Department of Internal Medicine, APOUI, Verona, Italy.
  • Iacovelli R; Oncology Unit, AOUI, Verona, Italy.
  • Fassan M; Department of Medicine (DIMED), University of Padua, Padua, PD, Italy.
  • Corbo V; ARC-NET Research Centre, University of Verona, Verona, Italy; Department of Diagnostics and Public Health, Section of Anatomical Pathology, University and Hospital Trust of Verona, Verona, Italy.
  • Brunelli M; Department of Diagnostics and Public Health, Section of Anatomical Pathology, University and Hospital Trust of Verona, Verona, Italy.
  • Artibani W; Urologic Unit, AOUI, Verona, Italy.
  • Scarpa A; ARC-NET Research Centre, University of Verona, Verona, Italy; Department of Diagnostics and Public Health, Section of Anatomical Pathology, University and Hospital Trust of Verona, Verona, Italy. Electronic address: aldo.scarpa@univr.it.
  • Lawlor RT; ARC-NET Research Centre, University of Verona, Verona, Italy.
Pathol Res Pract ; 214(10): 1675-1680, 2018 Oct.
Article in En | MEDLINE | ID: mdl-30190183

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Biomarkers, Tumor / TOR Serine-Threonine Kinases / Prostatic Neoplasms, Castration-Resistant Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Pathol Res Pract Year: 2018 Document type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Biomarkers, Tumor / TOR Serine-Threonine Kinases / Prostatic Neoplasms, Castration-Resistant Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Pathol Res Pract Year: 2018 Document type: Article Affiliation country: Italy